arrow
M

Mark N. Gaze

university college london hospitals nhs foundation trust
H指数:40
被引数:5,924

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dose-effect analysis of late dental adverse effects following radiation therapy in survivors of paediatric head and neck rhabdomyosarcoma

放疗后儿童头颈部横纹肌肉瘤幸存者晚期口腔不良反应的剂量-效应分析

2026-10-100
PRE
Exploration of the radiation dose-toxicity relationship for multiple ophthalmological organs at risk for pediatric patients assessed in long-term head and neck rhabdomyosarcoma survivors

探索长期头颈横纹肌肉瘤幸存患儿中多个眼科学风险器官的辐射剂量-毒性关系

2026-06-170
OAAI
DENTALE: a validated Dentofacial EvaluatioN Tool to standardize radiological Assessment of Late dental and maxillofacial adverse Effects following treatment for pediatric rhabdomyosarcoma

DENTALE:一种经过验证的牙颌评估工具,用于标准化对儿童横纹肌肉瘤治疗后晚期牙科及颌面部不良反应的放射学评估

2026-05-012
PRE
Systematic review of facial deformation following paediatric head and neck radiation therapy: A call for standardised outcome assessment and dose–response evidence

儿科头颈部放射治疗后面部变形的系统评价:呼吁标准化的结局评估和剂量-反应证据

2026-02-190
OAAI
Systematic Review of Late Dental Effects Following Head and Neck Radiation Therapy in Childhood Cancer Survivors

儿童癌症幸存者接受头颈部放射治疗后晚期牙科效应的系统评价

2026-02-190
OAAI
Anesthesia in Pediatric Radiotherapy: A Systematic Literature Review by the SIOP Europe Working Group on Pediatric Anesthesia in Radiation Therapy

儿科放射治疗中的麻醉:SIOP欧洲儿科放射治疗麻醉工作组系统文献综述

2026-01-011
PRE
Selection of the Most Appropriate Radiation Treatment Modality for Children's Cancers: A Paediatric Radiation Oncology Society (PROS) Position Paper on the Ethical Utilization of Proton Therapy

儿童癌症最适宜放疗方式的选择:儿科放射肿瘤学会(PROS)关于质子治疗伦理使用的立场文件

2025-11-010
PRE
Dental Adverse Effects Following Multimodality Treatment for Head and Neck Rhabdomyosarcoma: Results of a Trans-Atlantic Multicentre Study

头颈部横纹肌肉瘤多模式治疗后口腔不良反应:一项跨大西洋多中心研究的结果

2025-09-010
OA
Late toxicity after upper abdominal radiotherapy in pediatric Wilms tumor and neuroblastoma survivors. A systematic review on behalf of SIOPEN and SIOP-RTSG

上腹部放疗后的迟发性毒性:儿科肾母细胞瘤和神经母细胞瘤幸存者的系统综述。代表SIOPEN和SIOP-RTSG撰写。

2025-05-270
OA
Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study

Gaze, M.N.; Handkiewicz-Junak, D.; Hladun, R.; Laetsch, T.W.; Sorge, C.; Sparks, R.; Wan, S.; Ceraulo, A.; Kluczewska-Galka, A.; Gámez-Cenzano, C.; 等. [177Lu]Lu-DOTA-TATE在青少年患者中的安全性及剂量学研究,该患者群体具有生长抑素受体阳性的胃肠胰神经内分泌肿瘤,或嗜铬细胞瘤和副神经节瘤:NETTER-P研究II期试验的初步分析。欧洲核医学与分子影像学杂志,2025, 52, 4001–4015. [Google Scholar] [CrossRef]

2025-04-080
OA
The Impact of Radiation Therapy on Metastatic Rhabdomyosarcoma: Results From the EpSSG MTS 2008 Study
2025-02-010
PRE
Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following 177Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report
2024-09-110
OAAI